Literature DB >> 22378919

Executive dysfunction in adults with moyamoya disease is associated with increased diffusion in frontal white matter.

Lionel Calviere1, Guillaume Ssi Yan Kai, Isabelle Catalaa, Fabienne Marlats, Fabrice Bonneville, V Larrue.   

Abstract

BACKGROUND AND
PURPOSE: Alteration of the cerebrovascular reserve (CVR) in the frontal lobes has been associated with cognitive dysfunction in adults with moyamoya disease (MMD). Elevation of the apparent diffusion coefficient (ADC) in normal-appearing white matter on conventional MRI may occur as a consequence of chronic haemodynamic failure. In the present study, the authors examined the relation of ADC with CVR and cognitive dysfunction in adults with MMD.
METHODS: The authors measured ADC and CVR in the normal-appearing frontal white matter. CVR was calculated using dynamic susceptibility contrast-enhanced MRI and the acetazolamide challenge. A standardised and validated neuropsychological assessment test battery focusing on executive function was used.
RESULTS: 14 patients, 9 women and 5 men (mean age 36.6±12.9 years), were included. The authors found executive dysfunction in 7 of 13 tested patients. ADC and CVR were negatively correlated (Spearman coefficient: -0.46; p=0.015). Elevation of ADC predicted executive dysfunction (area under receiver operating characteristic curve (95% CI): 0.85 (0.59 to 1.16); p=0.032).
CONCLUSION: Elevation of ADC in the normal-appearing frontal white matter of adults with MMD was associated with reduced CVR and executive dysfunction. This preliminary study suggests that measurement of ADC might be used to detect patients at risk for cerebral ischaemia and cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378919     DOI: 10.1136/jnnp-2011-301388

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

Review 1.  Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusion.

Authors:  Yaron Gordon; Sasan Partovi; Matthias Müller-Eschner; Erick Amarteifio; Tobias Bäuerle; Marc-André Weber; Hans-Ulrich Kauczor; Fabian Rengier
Journal:  Cardiovasc Diagn Ther       Date:  2014-04

Review 2.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

3.  Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H215O PET.

Authors:  Constantin Roder; Patrick Haas; Monika Fudali; Monika Milian; Ulrike Ernemann; Philipp T Meyer; Marcos Tatagiba; Nadia Khan
Journal:  Neurosurg Rev       Date:  2019-11-14       Impact factor: 3.042

Review 4.  Late Cerebrovascular Events and Social Outcome after Adolescence: Long-term Outcome of Pediatric Moyamoya Disease.

Authors:  Takeshi Funaki; Jun C Takahashi; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-05-21       Impact factor: 1.742

5.  Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research.

Authors:  Jian Sun; Zhiyong Shi; Lebao Yu; Yujie Wen; Dong Zhang
Journal:  BMC Neurol       Date:  2022-01-06       Impact factor: 2.474

Review 6.  Efficacy and safety of 3-n-butylphthalide for the treatment of cognitive impairment: A systematic review and meta-analysis.

Authors:  Qiulu Zhou; Chao Han; Yun Xia; Fang Wan; Sijia Yin; Yunna Li; Liang Kou; Xiaosa Chi; Junjie Hu; Yadi Sun; Jiawei Wu; Wenkai Zou; Jinsha Huang; Tao Wang
Journal:  CNS Neurosci Ther       Date:  2022-09-01       Impact factor: 7.035

7.  Cognitive Functions in Children and Adults with Moyamoya Vasculopathy: A Systematic Review and Meta-Analysis.

Authors:  Annick Kronenburg; Esther van den Berg; Monique M van Schooneveld; Kees P J Braun; Lionel Calviere; Albert van der Zwan; Catharina J M Klijn
Journal:  J Stroke       Date:  2018-09-30       Impact factor: 6.967

8.  Microstructural damage pattern of vascular cognitive impairment: a comparison between moyamoya disease and cerebrovascular atherosclerotic disease.

Authors:  Jia-Bin Su; Si-Da Xi; Shu-Yi Zhou; Xin Zhang; Shen-Hong Jiang; Bin Xu; Liang Chen; Yu Lei; Chao Gao; Yu-Xiang Gu
Journal:  Neural Regen Res       Date:  2019-05       Impact factor: 5.135

9.  Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes.

Authors:  Zhiyong Shi; Yu-Jie Wen; Zheng Huang; Le-Bao Yu; Dong Zhang
Journal:  Stroke Vasc Neurol       Date:  2020-03-25

10.  Decreased frontal white-matter diffusion and improved cognitive flexibility after burr-hole surgery in moyamoya angiopathy.

Authors:  Lionel Calviere; Paul Loubiere; Melanie Planton; Vanessa Cazzola; Isabelle Catalaa; Helene Mirabel; Jean Christophe Sol; Fabrice Bonneville
Journal:  BMC Neurol       Date:  2020-01-20       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.